Dianna Sue Howard, M.D.
Professor, Hematology & Oncology
Leukemia, Myeloid, Acute; Glutathione Disulfide; Chromatography, Liquid; Tandem Mass Spectrometry; Glutathione
Academic: 336-716-4464 | Department: 336-716-4464
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort. Saeed H, Yalamanchi S, Liu M, Van Meter E, Gul Z, Monohan G, Howard D, Hildebrandt GC, Herzig R.. Hematol Oncol Stem Cell Ther. 2018;():.
A phase I study of CPI-613 in combination with high dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia. Pardee TS, Anderson RG, Pladna KM, Isom S, Ghiraldeli LP, Miller LD, Chou JA, Jin G, Zhang W, Ellis LR, Berenzon D, Howard DS, Hurd D, Manuel M, Dralle S, Lyerly S, Powell BL.. Clin Cancer Res. 2018;():.
Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit. Ahmed T, Koch AL, Isom S, Klepin HD, Bishop JM, Ellis LR, Berenzon D, Howard D, Lyerly S, Powell BL, Pardee TS.. Leuk Res. 2017;62():51-55.
Acute graft-versus-host disease in the setting of T cell depletion: validation of a new agvhd risk score [abstract]. Saeed H, Slone S, Yalamanchi S, Becton T, Monohan G, Howard D, Herzig R, Hildebrandt GC.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S410-S411.
Timing of salvage therapy and autologous hematopoietic cell transplant in relapsed hodgkin and non hodgkin lymphoma [abstract]. Lamar ZS, Fino N, Hurd D, Howard D, McIver ZA, Phillips GL, Vaidya R.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S127-S128.
Simultaneous quantitation of oxidized and reduced glutathione via LC-MS/MS: an insight into the redox state of hematopoietic stem cells. Carroll D, Howard D, Zhu H, Paumi CM, Vore M, Bondada S, Liang Y, Wang C, St Clair DK.. Free Radic Biol Med. 2016;97():85-94.
Activity of the mitochondrial metabolism inhibitor cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone in high risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. Pardee TS, Stadelman K, Isom S, Ellis LR, Berenzon D, Hurd DD, Howard DS, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL.. J Clin Oncol. 2015;33(15 Suppl):7015.
The mitochondrial metabolism inhibitor Cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone is highly active in poor risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. Pardee T, Pladna K, Isom S, Ellis LR, Berenzon D, Howard D, Manuel M, Dralle S, Hurd DD, Lyerly S, Powell BL.. Blood. 2015;126(23):2556.
Feasibility of a symptom-adapted physical activity intervention during induction chemotherapy for older adults with acute myeloid leukemia (AML) [abstract]. Klepin HD, Tooze J, Pardee T, Ellis LR, Berenzon D, Howard D, Demark-Wahnefried W, Mihalko S, Rejeski WJ, Powell BL, Kritchevsky S.. Blood. 2015;126(23):2102.
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Horton TM, Perentesis JP, Gamis AS, Alonzo TA, Gerbing RB, Ballard J, Adlard K, Howard DS, Smith FO, Jenkins G, Kelder A, Schuurhuis GJ, Moscow JA.. Pediatr Blood Cancer. 2014;61(10):1754-1760.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Professor, Hematology & Oncology
Acute and Chronic Leukemia, Acute Leukemias, Myelodysplastic Syndromes, Blood and Marrow Transplant, Hematologic Malignancies, Multiple Myeloma, Hematopoietic Stem Cell Transplantation, Bone Marrow and Stem Cell Transplantation, Leukemia
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
*Dr. Howard is the "best."
Needed whooping cough booster - taken care of immediately.
My doctor is the best! Can't imagine how I could get better treatment from anyone else!
I appreciated the care and friendliness of this provider.
I really like Dr. Howard and look forward to being her patient!
Dr. Howard and her entire team have been great. They are very knowledgeable, compassionate, understanding and helpful. They always take the time to listen to my concerns and together we gone up with a treatment plan that works for me. This has been a long difficult journey and Dr. Howard, Mary, Brooke and Allison made it tolerable.
Dr. Howard was WONDERFUL!! She took the time to make sure I understood everything and even took the time to make sure my mom's questions were answered. She never rushed us even though my time with her was affected by the check in process.
Dr. Howard is wonderful very caring just the Best!
*Dr. Howard is the best. I'm sure I wouldn't be alive today w/out her. She is caring, _____ & all around AMAZING!
the cancer team saved my life.
*Dr. Howard had been really great along with everybody else.
*Dr. Howard has a sweet caring bedside manner second to none.
Diana Howard is the total physician. While treating your medical condition , she simultaneously makes you realize that she truly cares about the concerns, emotions, and questions of the PERSON behind the Patient Number. This wonderful trait, paired with her vast knowledge in this specialty area, is what makes her successful.